clinical trial · NCT05358886
A Study of BPN14770 in Male Adults (Aged 18 to 45) With Fragile X Syndrome
Tetra Discovery Partners·phase3·completed·n = 171
Fragile X SyndromeBPN14770/ zatolmilastPlacebo
brief summary
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of BPN14770 in Male Adults (Aged 18 to 45) with Fragile X Syndrome
started
Nov 1, 2022
primary completion
Jul 18, 2025
completion
Jul 18, 2025
last updated
Jul 23, 2025
official title
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of BPN14770 in Male Adults (Aged 18 to 45) With Fragile X Syndrome
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol